Land: Vereinigtes Königreich
Sprache: Englisch
Quelle: MHRA (Medicines & Healthcare Products Regulatory Agency)
Lamotrigine
GlaxoSmithKline UK Ltd
N03AX09
Lamotrigine
2mg
Dispersible tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04080100; GTIN: 5010706010147
What is in this leaflet 1 WHAT LAMICTAL IS AND WHAT IT IS USED FOR 2 WHAT YOU NEED TO KNOW BEFORE YOU TAKE LAMICTAL 3 HOW TO TAKE LAMICTAL 4 POSSIBLE SIDE EFFECTS 5 HOW TO STORE LAMICTAL 6 CONTENTS OF THE PACK AND OTHER INFORMATION Other formats To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge: 0800 198 5000 (UK only) Please be ready to give the following information: PRODUCT NAME LAMICTAL 2 MG CHEWABLE/DISPERSIBLE TABLETS LAMICTAL 5 MG CHEWABLE/DISPERSIBLE TABLETS LAMICTAL 25 MG CHEWABLE/DISPERSIBLE TABLETS LAMICTAL 100 MG CHEWABLE/DISPERSIBLE TABLETS Reference number 00003/0375 This is a service provided by the Royal National Institute of Blind People. Lamictal belongs to a group of medicines called _anti-epileptics_. It is used to treat two conditions - EPILEPSY and BIPOLAR DISORDER. LAMICTAL TREATS EPILEPSY by blocking the signals in the brain that trigger epileptic seizures (fits) • For adults and children aged 13 years and over, Lamictal can be used on its own or with other medicines, to treat epilepsy. Lamictal can also be used with other medicines to treat the seizures that occur with a condition called Lennox-Gastaut syndrome. • For children aged between 2 and 12 years, Lamictal can be used with other medicines, to treat those conditions. It can be used on its own to treat a type of epilepsy called typical absence seizures. LAMICTAL ALSO TREATS BIPOLAR DISORDER People with bipolar disorder (sometimes called_ manic _ _depression_) have extreme mood swings, with periods of mania (excitement or euphoria) alternating with periods of depression (deep sadness or despair). For adults aged 18 years and over, Lamictal can be used on its own or with other medicines, to prevent the periods of depression that occur in bipolar disorder. It is not yet known how Lamictal works in the brain to have this effect. Do not take Lamictal: • IF YOU ARE ALLERGIC (_hypersensitive_) to lamotrigine or any of the other ingredients of this medicine (listed in Section 6 Lesen Sie das vollständige Dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Lamictal 2 mg chewable/dispersible tablets. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each Lamictal 2 mg chewable/dispersible tablet contains 2 mg lamotrigine. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet. Chewable/dispersible tablet. White to off white round tablets of 4.8 mm with a blackcurrant odour. One side has a bevelled edge and is marked “LTG” above the number 2. The other side is marked with two overlapping super ellipses at right angles. The tablets may be slightly mottled. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Epilepsy _Adults and adolescents aged 13 years and above _ - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures associated with Lennox-Gastaut syndrome. Lamictal is given as adjunctive therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-Gastaut syndrome. _Children and adolescents aged 2 to 12 years _ - Adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut syndrome. - Monotherapy of typical absence seizures. Bipolar disorder _Adults aged 18 years and above_ - Prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes (see section 5.1). Lamictal is not indicated for the acute treatment of manic or depressive episodes. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Lamictal chewable/dispersible tablets may be chewed, dispersed in a small volume of water (at least enough to cover the whole tablet) or swallowed whole with a little water. If the calculated dose of lamotrigine (for example for treatment of children with epilepsy or patients with hepatic impairment) does not equate to whole tablets, the dose to be administered is that equal to the lower number of whole tablets. Restarting therapy Prescribers should assess the need for escal Lesen Sie das vollständige Dokument